Conception Bio
Advancing the future of fertility.
Berkeley, United States · Founded 2018 · $38.0M raised
- Headquarters
- Berkeley, California
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- conception.bio
- Total Funding
- $38.0M
- Last Round
- $8.0M Venture RoundJan 2024
- Rounds
- 3
About
Conception is a Berkeley-based biotechnology company developing in-vitro gametogenesis (IVG) technology to generate functional human egg cells from induced pluripotent stem cells (iPSCs). The company combines stem cell biology, 3D ovarian organoid engineering, and computational genomics to recreate the key developmental stages from iPS cells through primordial germ cells to mature eggs. High-throughput genetic screens and computer vision-based quality scoring enable rapid iteration across differentiation conditions. Conception's goal is to make biological parenthood possible for people facing age-related fertility decline or medical barriers, subject to future regulatory approval.
Summary
Conception Bio is a Biotech company based in Berkeley, United States, founded in 2018. It has raised $38.0M in total across 3 rounds, most recently a $8.0M Venture Round round in Jan 2024.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...